NFL Biosciences SAS (ALNFL) — Financial Flexibility Index
NFL Biosciences SAS (ALNFL) has a Financial Flexibility Index of 0.02x as of June 2023. Free cash flow of €57.51K (operating CF €57.51K minus capex €0.00) represents 0% of total liabilities (€3.67 Million). Check ALNFL strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NFL Biosciences SAS Financial Flexibility Index (2020–2022)
Historical Financial Flexibility Index trend for NFL Biosciences SAS across 3 annual periods. See ALNFL working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for NFL Biosciences SAS (2020–2022)
Year-by-year free cash flow to debt coverage for NFL Biosciences SAS. For the full company profile including market capitalisation, see NFL Biosciences SAS market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.07x | €104.89K | €104.89K | €1.55 Million | ▼ -69.1% |
| 2021 | 0.22x | €87.00K | €87.00K | €397.73K | ▲ +11.2% |
| 2020 | 0.20x | €83.91K | €83.91K | €426.61K | — |